Factors Associated With Chemoradiation Therapy Interruption and Noncompletion Among Patients With Squamous Cell Anal Carcinoma | Zendy

Michael J. Raphael | Zendy; Gary T.C. Ko | Zendy; Christopher M. Booth | Zendy; Susan B. Brogly | Zendy; Wenbin Li | Zendy; Maria Kalyvas | Zendy; Timothy P. Hanna | Zendy; Sunil V. Patel | Zendy

Open Access

Factors Associated With Chemoradiation Therapy Interruption and Noncompletion Among Patients With Squamous Cell Anal Carcinoma

Author(s) -

Michael J. Raphael,

Gary T.C. Ko,

Christopher M. Booth,

Susan B. Brogly,

Wenbin Li,

Maria Kalyvas,

Timothy P. Hanna,

Sunil V. Patel

Publication year - 2020

Publication title -

jama oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 8.846

H-Index - 99

eISSN - 2374-2445

pISSN - 2374-2437

DOI - 10.1001/jamaoncol.2020.0809

Subject(s) - medicine , anal cancer , radiation therapy , hazard ratio , cancer registry , cancer , population , proportional hazards model , surgery , confidence interval , environmental health

Definitive chemoradiation for anal cancer is effective but may be associated with toxic effects, and some patients may not be able to complete the planned treatment. Identifying factors associated with treatment interruption and noncompletion is important to target quality improvement efforts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research